Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Revenue

Celldex Therapeutics had revenue of $3.19M in the quarter ending September 30, 2024, with 110.35% growth. This brings the company's revenue in the last twelve months to $9.98M, up 128.55% year-over-year. In the year 2023, Celldex Therapeutics had annual revenue of $6.88M with 192.02% growth.

• Revenue (ttm): $9.98M
• Revenue Growth: +128.55%
• P/S Ratio: 153.27
• Revenue / Employee: $62,350
• Employees: 160
• Market Cap: 1.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.88M	4.53M	192.02%
Dec 31, 2022	2.36M	-2.29M	-49.32%
Dec 31, 2021	4.65M	-2.77M	-37.30%
Dec 31, 2020	7.42M	3.85M	107.61%
Dec 31, 2019	3.57M	-5.97M	-62.54%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.